Literature DB >> 3493134

Ribosomal protein phosphorylation in vivo and in vitro by vaccinia virus.

B Buendia, A Person-Fernandez, G Beaud, J Madjar.   

Abstract

Ribosomal protein phosphorylation was investigated in Ehrlich ascites tumor cells infected with vaccinia virus (Copenhagen strain). After 90 min of simultaneous infection and 32P-labelling, ribosomal proteins Sa, S2 and S13 appear specifically phosphorylated as well as Sb/La, P1 and S6, which are also phosphorylated in control cells. Sa is an acidic protein, whose phosphorylation has not been observed previously. A kinetic study showed that S2 is phosphorylated very rapidly within 10 min after the beginning of infection and it is complete 1 h later. The phosphorylation of S13 begins after a lag time of about 1 h and is completed after about 2.5 h of infection. Moreover only one phosphate is incorporated into S13 on a serine residue while up to four phosphates are incorporated into S2, the first on a serine and the three following on threonine residues. In vivo experiments, carried out in the presence of cycloheximide and cordycepin, suggest a viral origin for the kinase involved in the phosphorylation of S2 and S13. Moreover, in vitro experiments demonstrated that the kinase associated with the viral cores is capable of phosphorylating S2 on a serine residue only. In our cell/virus system, no significant difference in S6 phosphorylation was detected, when compared to uninfected cells. It is concluded that the specific and efficient phosphorylation of three ribosomal proteins from the 40S ribosomal subunit correlate well with possible translational mechanisms ensuring the efficient expression of early and late genes of vaccinia virus. In the light of these and previous results [Person, A. and Beaud, G. (1986) J. Biol. Chem. 261, 8283-8289], a mechanism is proposed for the shut-off of host protein synthesis and the selective translation of mRNAs of viral origin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493134     DOI: 10.1111/j.1432-1033.1987.tb10547.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.

Authors:  Ann Chahroudi; David A Garber; Patrick Reeves; Luzheng Liu; Daniel Kalman; Mark B Feinberg
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Microtubule-dependent organization of vaccinia virus core-derived early mRNAs into distinct cytoplasmic structures.

Authors:  M Mallardo; S Schleich; J Krijnse Locker
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

3.  Ribosome and protein synthesis modifications after infection of human epidermoid carcinoma cells with herpes simplex virus type 1.

Authors:  T Masse; D Garcin; B Jacquemont; J J Madjar
Journal:  Mol Gen Genet       Date:  1990-02

4.  RACK1 Regulates Poxvirus Protein Synthesis Independently of Its Role in Ribosome-Based Stress Signaling.

Authors:  Chorong Park; Derek Walsh
Journal:  J Virol       Date:  2022-09-13       Impact factor: 6.549

5.  Proteomic and mechanistic dissection of the poxvirus-customized ribosome.

Authors:  Stephen DiGiuseppe; Madeline G Rollins; Helen Astar; Natalia Khalatyan; Jeffrey N Savas; Derek Walsh
Journal:  J Cell Sci       Date:  2020-07-09       Impact factor: 5.285

6.  Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase.

Authors:  G Beaud; R Beaud; D P Leader
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 7.  Fatal attraction: The roles of ribosomal proteins in the viral life cycle.

Authors:  Clare M Miller; Sangeetha Selvam; Gabriele Fuchs
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-07-12       Impact factor: 9.957

Review 8.  Selective regulation in ribosome biogenesis and protein production for efficient viral translation.

Authors:  Hui-Jun Dong; Rui Zhang; Yu Kuang; Xiao-Jia Wang
Journal:  Arch Microbiol       Date:  2020-10-29       Impact factor: 2.552

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.